A 72-year-old with stable angina and EF 30% on ACEI/β-blocker/MRA asks about SGLT2 inhibitors. Which is true?...

Question

A 72-year-old with stable angina and EF 30% on ACEI/β-blocker/MRA asks about SGLT2 inhibitors. Which is true?

Accepted Answer

SGLT2 inhibitors reduce HF hospitalisation and CV death in HFrEF regardless of diabetes

Answer

Use only if diabetes present

Answer

They worsen renal outcomes

Answer

They are contraindicated with MRAs

Answer

They replace ACEI

us-abim MCQ (SBA): HFrEF-SGLT2 Inhibitors